Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
https://www.google.com/search?q=fruci+and+associates+cbd+of+denver&oq=&aqs=chrome.1.69i177j35i39l3j46.-1j0j7&client=ms-android-verizon&sourceid=chrome-mobile&ie=UTF-8
Click on or copy and paste above.... Oh yeah, look at all the eyes watching...$$$$
https://www.digitaljournal.com/pr/cbd-of-denver-nears-completion-of-gaap-audit
And many many more articles on this current December CBDD Audit.
Plenty eyes watching
CBDD - December 7, 2021 / current advisory: BUY
CBDD is way undervalued !
All well said.... The CBDD team was doing great, now with Nicholas, team is expanding, more time for Marcel to concentrate on his end of things, Nick on PR, most likely sales team growing, revenue growth, products expanding, customer base expanding, AWESOME !!!
The Audit, Uplisting, Legalization coming. Patience & Long Hold !
Good morning briz
Yes Prpeniszoid, the knocking negative statements of CBDD here are borderline defaming a company. Very unprofessional and showing a complete lack of courtesy and patience to others here, and possible new investors.
CBDD - PATIENCE AND LONG LONG HOLD $$$$
CBDD Stock Rating 69
CBD Of Denver Inc Stock Rating: Buy, Sell or Hold?
CBD Of Denver Inc (CBDD) is a Buy
CBD Of Denver Estimiated After-Hype Price Volatility
In the context of predicting CBDD otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CBDD historical news coverage. CBDD after-hype downside and upside margins for the prediction period are $0.00 and $4.56, respectively. We have considered CBDD daily market price in relation to the headlines to evaluate this method's predictive performance.
Predicted Opening Price for CBD of Denver Inc. of Tuesday, November 30, 2021
Fair opening price November 30, 2021 Current price
$0.0049 (Undervalued)
CORRECTION (MaddAussi)
Swiss Audit is completed, the negative posts here must be competators of CBDD. mojo joyo & MaddAussie NEVER have anything positive to say... NEVER !
Is that really being an investor with CBDD... NO !!! At this point I can clearly say they both probably do not hold stock with CBDD.
Well said and nicely presented MrCoopa
I see we're all posting this great news, great third quarter, Nick Sprung, Sales, growth, etc. GO CBDD
CBD of Denver Files Q3 Financial Statements and Reports Revenue Up 300% Year-Over-Year in the First Nine Months of 2021
Newsfile Corp.
December 2, 2021, 7:30 am
Denver, Colorado--(Newsfile Corp. - December 2, 2021) - CBD of Denver, Inc. (OTC Pink: CBDD), a cultivator and distributor of CBD and cannabis flower and a producer of a full line of CBD oil and unique products sold in Switzerland and throughout Europe, filed its third quarter financial statements on OTCMarkets.com for the period ended September 30, 2021.
CBD of Denver generated $20.9 million revenue in the first nine months of 2021, up 300% year-over-year compared to $6.0 million in the first nine months of 2020. Gross profit in the first nine months of 2021 was $1.1 million, compared to gross profit of $0.5 million in the same period of 2020.
Q3 Business Highlights:
Customer base increased to over 800 customers across Europe, including more than 450 recurring customers, as of the end of the third quarter of 2021
Delivering products into 12 countries across Europe as of the end of the third quarter of 2021
"We are very pleased to report strong year-over-year revenue growth in the first nine months of 2021, and importantly, year-to-date, we have already surpassed our 2021 revenue guidance of $22 million (USD)," commented Marcel Gamma, CEO. "The Company remains focused on continued growth while simultaneously moving forward on the completion of its GAAP audit required to become a fully reporting issuer with the SEC, which will enable the Company to move beyond the OTC Pink Market where it can provide investors with improved transparency and increased liquidity."
A key driver of the Company's year-to-date performance has been its Rockflowr brand. CBD of Denver has successfully completed a rebranding Rockflowr, GmbH to Rockflowr Exchange and Rockflowr Production as it works to become the top European player in the space.
CBD of Denver Retires Preferred Shares Early, Eliminates Potential Equity Dilution
Newsfile Corp.
September 30, 2021·2 min read
In this article:
Denver, Colorado--(Newsfile Corp. - September 30, 2021) - CBD of Denver, Inc. (OTC Pink: CBDD), a full-line CBD and hemp oil company and a producer and distributor of cannabis and CBD products in Switzerland and Europe, is pleased to announce that the Company has retired 13 of its 18 preferred shareholders who had purchased preferred shares issued in previous years.
"As our financial position has improved dramatically this year, we were able to capitalize on this opportunity to drive value for our shareholders through the elimination of potential dilution from those preferred shares by purchasing and retiring them," stated Marcel Gamma, CEO of CBD of Denver. "Given the recent decline in our stock price, retiring those shares allowed us to avoid unnecessary dilution and protect our shareholders."
Patience and Long Long Long Hold
0.00 - 4.59 ??????
CBDD
About Macroaxis
My Equities
My Portfolios
Investing Opportunities
Crypto Center
Stories Depot
Market Map
Research Hub
Cbd Of Denver OTC Stock Future Price Prediction
OTC Stocks USA Stock Cbd Of Denver
SUMMARY PERFORMANCE FUNDAMENTALS TECHNICALS ADVICE
Profile Financials Valuation Risk Headlines Prediction Leverage Analysis
Cbd Of Denver Estimiated After-Hype Price Volatility
In the context of predicting Cbd Of Denver's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cbd Of Denver's historical news coverage. Cbd Of Denver's after-hype downside and upside margins for the prediction period are 0.00 and 4.59, respectively. We have considered Cbd Of Denver's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
All 46 cannabis stocks are in LONG LONG HOLD.... PATIENCE
I have 46 cannabis stocks, all down.
You can blah ba blah all you want about Marcel Gamma. He's doing GREAT..! Who and what keeps shorting this can only do it for so long.
mojo joyo, you can stop crying about it. IT'S NOT GONNA HAPPEN NOV. DEC. 2021 maybe see some action here JAN.-APR. 2022. UNTILL LEGALIZATION...2022
No secret
CBDD is GROWING, moving like a train without brakes..! Don't let low stock price discourage you. All cannabis stocks are in dip mode.
Key: US Legalization pass before 2022 midterms is the current goal.
CBDD is GROWING, moving like a train without brakes..! Don't let low stock price discourage you. All cannabis stocks are in dip mode.
Key: US Legalization pass before 2022 midterms is the current goal.
CBD of Denver Enhances Shareholder Communications with Appointment of Nicholas Sprung to Its Board
Newsfile Corp.
November 30, 2021, 7:30 am
Denver, Colorado--(Newsfile Corp. - November 30, 2021) - CBD of Denver, Inc. (OTC Pink: CBDD), a cultivator and distributor of CBD and cannabis flower and a producer of a full line of CBD oil and unique products sold in Switzerland and throughout Europe, is pleased to announce the appointment of Nicholas Sprung, the Company's former President and CEO, to its Board of Directors.
As a Director of CBD of Denver, Sprung is being tasked with enhancing investor communications with both current and prospective shareholders, enabling management to remain focused on the day-to-day operations and growth of the Company.
"I understand the constraints that the management team has faced in Switzerland and their desire to improve shareholder communications," commented Sprung. "I am pleased to have been invited to return to lead this important initiative as a Director of CBD of Denver. Accurately and clearly communicating the Company's progress to the investment community is critical to our long-term success, and I look forward to keeping shareholders and potential new investors informed."
"I am very happy that we have Nicholas back on board, and he is a great asset to the management team," says Marcel Gamma, CEO of CBD of Denver. "We believe that with Nicholas' support, we will be able to significantly improve our communications to investors and shareholders and hopefully, over time, strengthen confidence in our company from the investor community."
Follow CBDD on Instagram: @SwissCBDTrading @Rockflowr @CBDofDenver_Inc @SwissGreenGrow @RockflowrRetail
Keep in mind that CBDD has an outstanding chance, very possibly be in the Top 5 growers in Europe...$$$
CBD of Denver Comments on Progress of Cannabis Legalization Efforts in Switzerland
Newsfile Corp.
October 21, 2021, 8:04 am
Denver, Colorado--(Newsfile Corp. - October 21, 2021) - CBD of Denver, Inc. (OTC Pink: CBDD), a full-line CBD and hemp oil company and a producer and distributor of cannabis and CBD products in Switzerland and Europe, comments on Switzerland's Commission for Social Security and Health of the Council of States' (SGK-S) nine to two vote in favor of cannabis legalization. Switzerland's National Council Commission (SGK-N) previously voted in favor of cannabis legalization with a vote of 13 to 11 in April 2021.
"Once again, the Swiss government is sending a clear signal of its support of cannabis legalization," commented Marcel Gamma, CEO of CBD of Denver. "This latest step forward further confirms our strategy to make Switzerland a cornerstone of our growing European operations as the country moves toward playing a leading role in legalization in Europe."
Financial Analytical Systems Group, Current News for CBDD;
Great news ahead, rated BUY.
Patience & Long Hold $ CBDD $
Gamma. "Despite these market challenges, I am confident our team will continue to perform at exceptional levels, as demonstrated by our 73% year-over-year growth during the March through October period, reaching $17.9 million and representing 79% of our year-to-date total revenues."
Agree briz...100% Good morning to you
Last year was CBDD's first climbing year, and 2021 was climbing in sales and expanding. Are some of us here that serious to think everything is going to climb sky high, like now ? lol. Patience Long Hold..!
mojo joyo: "It doesn't looks like it the way this start trading.
No audits price will stay the same .sucks here all is on Marcel."
IF IT SUCKS HERE, LEAVE..!
Hey joyo, but after 2 year audit they are filing Form 10 with the SEC. Investors have patience unlike you.
Kaleo... Exactly. And the negative winners are mojo & MaddAussi. I called out mojo a month or so ago, and now I'm calling out MaddAussi. Spewing unknowledgeable negative statements about CBDD every single day. It's obvious. BS Artists..! Keep up the negative work.
One of my stocks news today; "Company completes 2-year audit and will be subject to the reporting requirements of the SEC exchange act of 1934 as amended it's regulation A offering is fully subscribed for 5 million"
And some here are crying foul with CBDD Audit...
PATIENCE & HOLD LONG